Earnings Call · Q2 FY2022·2022-08-08

Q2 22EPS +17.02%·Rev n/aQ1 22EPS +18.07%·Rev n/aQ4 21EPS -100.00%*·Rev n/aQ3 21EPS +100.00%*·Rev n/a⚠ consensus missing

KYNTRA BIO, INC. FGEN

Michael Tung — Vice President of Corporate Strategy and Investor Relations

Enrique Conterno — Chief Executive Officer

Juan Graham — Chief Financial Officer

−3.3%1d on move date−2.9% vs SPY3d−3.8%5d−0.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FGEN calls or request research access.

More FGEN calls Browse calls Request research access